BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11417181)

  • 1. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
    Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
    Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
    Siergiejko Z; Obrzut D; Rogalewska A
    Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Sov Med; 1988; (5):69-72. PubMed ID: 3062806
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of lasolvan on the rheologic properties of sputum].
    Chuchalin AG; Solopov VN; Kolganova NA; Plisko LF
    Klin Med (Mosk); 1987 Mar; 65(3):52-4. PubMed ID: 3298838
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selection of expectorants in the treatment of asthma and chronic bronchitis].
    Obtulowicz K; Maternowska W; Lukasiewicz W; Szczeklik A
    Pol Tyg Lek; 1977 Jan; 32(1):29-31. PubMed ID: 319439
    [No Abstract]   [Full Text] [Related]  

  • 7. [The efficacy of using ditek and Lasolvan in children with bronchial asthma].
    Fesenko NIe; Horishna OV; Ponomarenko LM; Astakhova NH; Fesenko SM; Koval'ova IeM; Myzhina TSh; Kozakevych VK
    Lik Sprava; 1998; (5):115-6. PubMed ID: 9793326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of the chronic bronchitic syndrome with Ozothine].
    Nonhoff R
    Med Monatsschr; 1967 Aug; 21(8):367-70. PubMed ID: 5597098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
    Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
    Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis].
    Michnar M; Milanowski J
    Pneumonol Alergol Pol; 1996; 64 Suppl 1():90-6. PubMed ID: 9190245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental studies on bronchial secretion. Therapeutical aspects of pathological bronchial secretion.
    Simonsson BG
    Scand J Respir Dis Suppl; 1974; 90():1-89. PubMed ID: 4618374
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with ambroxol syrup (author's transl)].
    Göbel P; Rensch H
    Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
    Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
    Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The complex assessment of disordered bronchial patency in chronic obstructive lung diseases].
    Ovcharenko SI; Filippov VV
    Ter Arkh; 1990; 62(11):63-6. PubMed ID: 2094994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
    Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
    Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secretolytic bisolvon in the treatment of chronic bronchitis and bronchial asthma].
    Beritić T
    Lijec Vjesn; 1968; 90(8):775-9. PubMed ID: 4888799
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of some clinical-pharmacological studies on ambroxol (NA 872)].
    Renovanz VK
    Arzneimittelforschung; 1975 Apr; 25(4):646-52. PubMed ID: 1174081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.